Skip to content

Enviomycin

ANTIINFECTIVES FOR SYSTEMIC USE

Also known as: enviomycin sulfate, Tuberactinomycin N

ATC J04AB06

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Enviomycin is a drug catalogued in DrugCentral. Recorded indications include Pulmonary tuberculosis.

  • Indications: Pulmonary tuberculosis.
  • ATC code: J04AB06 (Antibiotics).
  • Molecular formula: C25H43N13O10; molecular weight 685.70 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Pulmonary tuberculosis

ATC classification

ATC codeTherapeutic hierarchy
J04AB06ANTIINFECTIVES FOR SYSTEMIC USE › ANTIMYCOBACTERIALS › DRUGS FOR TREATMENT OF TUBERCULOSIS › Antibiotics

Chemical structure

Molecular formulaC25H43N13O10
Molecular weight685.70 g/mol
CAS number—
InChIKeyHPWIIERXAFODPP-MYIPQGGFSA-N
PubChem CID135565326
NCC[C@@H](O)[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@@H](NC(=O)C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O)=CNC(N)=O)[C@H]1CCNC(N)=N1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Enviomycin used for?

DrugCentral lists the following indications for Enviomycin: Pulmonary tuberculosis.

What is the chemical formula of Enviomycin?

Enviomycin has the molecular formula C25H43N13O10 and a molecular weight of 685.70 g/mol.

Browse: all drugs starting with E · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets0
Indications1
FormulaC25H43N13O10
DrugCentral ID3180
Interactive profile